We hypothesized that CSF IL-3 may act in the upstream process of sTREM2 in response to AD pathology, as confirmed by an in vivo study suggesting that IL-3 receptor alpha (IL-3Rα) is TREM2-dependent involved in microglial immune response [12]. Here, TREM2 is linked to Alzheimer disease.